Broadly neutralizing antibodies (bNABs) as a component of an HIV cure: results from the TITAN study

Drs Jesper D. Gunst PhD, Thomas A. Rasmussen PhD and Ole S. Søgaard PhD of Aarhus University Hospital, Denmark share